Provant Therapy System
Commercial- Indications
- Pain, Edema
Company intelligence / Profile preview
The Provant Therapy System and related products are FDA-cleared for palliative treatment of post-operative pain and edema in superficial soft tissues. The company reports commercial sales with a $20M+ run rate and positive cash flow. Clinical results support use for non-invasive, non-drug pain relief at home or in clinical settings. No ongoing pharmaceutical clinical trials as it markets cleared devices.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Regenesis Biomedical.